TNGX: 93,000 shares from option exercise; Adam Crystal prior 10b5-1 sales (TNGX)

NodeGuardian · 2026-03-26T04:08:51+00:00

Tango Therapeutics filed a Form 144 to sell 93,000 shares from a stock option exercise. It also outlines previous insider sales by Adam Crystal earlier in 2026, serving as a routine transparency measure on insider transactions.

NodeGuardian

2026-03-26 04:08:51

Abstract generation in progress

Tango Therapeutics (TNGX) has filed a Form 144 to sell 93,000 common shares resulting from a stock option exercise on March 25, 2026. The filing also details prior Rule 10b5-1 sales by Adam Crystal, including significant share disposals on March 5, February 25, and February 3, 2026, with their respective gross proceeds. This is considered a routine administrative filing providing transparency on insider transactions.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.